Man Group’s Zomedica Corp. ZOM Stock Holding History

Man Group’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-32,800	Closed	-$27K	–	2203
2021 Q2	$27K	Buy	+32,800	New	+$30.6K	﹤0.01%	1905

Other funds holding ZOM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $174B AUM 30.96% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group's ZOM Position: Q3 2021 in Review

Man Group sold out of Zomedica Corp. (ZOM) in Q3 2021, closing a stake of 32,800 shares — an estimated $27K sold.

Man Group first reported a position in ZOM in Q2 2021 and held it in 1 quarter. The position peaked at $27K in Q2 2021. 107 funds tracked by Wall St. Rank hold ZOM as of Q3 2021.

Man Group reported no remaining Zomedica Corp. position as of Q3 2021 after selling out during the quarter.
Man Group sold 32,800 Zomedica Corp. shares in Q3 2021, an estimated $27K.
Man Group first reported a position in Zomedica Corp. in Q2 2021 and held it in 1 quarter.
Man Group's Zomedica Corp. position peaked at $27K in Q2 2021.
107 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2021.

Based on Man Group's 13F filing for Q3 2021, filed 15 Nov 2021.